Inclusion & Diversity Pledge - Oral Oncology Reports View all announcements More opportunities to publish your research: Browse open Calls for Papers Partner journals Oral Oncology Supports open access 8.7CiteScore 4.0Impact Factor A Journal Related to Head & Neck Oncology Oral Oncology is an internati...
影响因子(Impact Factor, IF)是衡量期刊学术影响力的核心指标,通常以过去两年内期刊文章的平均被引频次计算。IF越高,表明期刊的研究成果被同行引用和关注的频率越高。《Oral Oncology》的IF达到4.8分,在医学领域的肿瘤学期刊中处于中等偏上水平,尤其在口腔癌、头颈部肿瘤细分领域属于...
Oral Oncology Oral Oncology Supports open access 8.7CiteScore 4.0Impact Factor Volume 157 October 2024 Download full issue Actions for selected articles Select all/Deselect all Download PDFs Export citations Show all article previewsShow all article previews...
学科:ONCOLOGY SCIE Q1 62 / 322 80.9% 名词解释: 汤森路透每年出版一本《期刊引用报告》(Journal Citation Reports,简称JCR)。JCR对86000多种SCI期刊的影响因子(Impact Factor)等指数加以统计。JCR将收录期刊分为176个不同学科类别在JCR的Journal Ranking中,主要参考当年IF,最终每个分区的期刊数量是均分的。 期...
Oral Oncology Reports Open access Oral Oncology Reports(OOR), a companion title toOral Oncology, is an online-only, peer-reviewed, open access journal. OOR provides an international interdisciplinary forum for the rapid publication of research relating to biology, diagnosis and treatment of neoplasms...
主要研究方向:医学-DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科;ONCOLOGY 肿瘤学 ORAL RADIOLOGY《口腔放射学》 国际标准刊号:ISSN 0911-6028;EISSN1613-9674 核心类别:SCIE(2022版), 外文期刊, 投稿网址:editorialmanager.com/or 期刊网址:springer.com/journal/11 所属分区:4区 是否TOP:非TOP期刊 是否综...
Journal Impact Factor: 2.6 5-year Journal Impact Factor: 3.2 Source Normalized Impact per Paper (SNIP): 1.205 SCImago Journal Rank (SJR): 0.737 Speed 2024 Submission to first editorial decision (median days): 15 Submission to acceptance (median days): 118 ...
Cancer, being one of the most lethal diseases, is causing significant demand for oral Immunostimulant agents responsible for modulating immune responses, and the oncology sector has emerged as one of the first growth drivers for the market owing to the myriad of opportunities generated by cancer imm...
Based on application, the oncology segment accounted for the leading share of the global market in 2022. Based on region, North America captured the largest share of the global market in 2022. Impact of COVID-19 on the therapeutic protein and oral vaccine market: ...
It's impact on survival should emerge rapidly from a larger series with longer follow-up. 066 A PILOT STUDY OF SPHINCTER- SPARING SURGERY, ENDOLUMINAL & EXTERNAL BEAM RAD IOERAPY IN RECTAL CANCER AC McDlnald*1, M Herthsmaim2' C Makin3 and S Myint. ICLattebridge Centre for Oncology, ...